Similar articles for PMID: 19605755

Year	Number of Results
1988	1
1989	1
1990	1
1991	1
1994	1
1995	5
1996	1
1997	1
1999	3
2001	1
2002	2
2003	2
2004	1
2005	5
2006	9
2007	2
2008	21
2009	65
2010	6
2011	3
2012	3
2013	6
2014	6
2015	2
2017	2
2018	1
2019	7
2020	2
2022	2
2024	0

1

Triple antithrombotic management after stent implantation: when and how?

Schömig A, Sarafoff N, Seyfarth M. Schömig A, et al. Heart. 2009 Aug;95(15):1280-5. doi: 10.1136/hrt.2008.160457. Heart. 2009. PMID: 19605755 Review. No abstract available.

2

Dual antiplatelet therapy and antithrombotic treatment: Recommendations and controversies.

Bryniarski L, Pelc-Nowicka A, Zabojszcz M, Mirek-Bryniarska E. Bryniarski L, et al. Cardiol J. 2009;16(2):179-89. Cardiol J. 2009. PMID: 19387970 Free article. Review.

3

Antithrombotic drugs.

[No authors listed] [No authors listed] Treat Guidel Med Lett. 2011 Oct;9(110):61-6; quiz 2 p following 66. Treat Guidel Med Lett. 2011. PMID: 21941228 No abstract available.

4

[A reference to know: the 2008 Chest Supplement on antithrombotic agents].

de Moerloose P, Fontana P, Boehlen F. de Moerloose P, et al. Rev Med Suisse. 2009 Jan 14;5(186):110-3. Rev Med Suisse. 2009. PMID: 19238928 French.

5

Guidelines for antithrombotic therapy: periprocedural management of antithrombotic therapy and use of bridging anticoagulation.

Spyropoulos AC, Douketis JD. Spyropoulos AC, et al. Int Angiol. 2008 Aug;27(4):333-43. Int Angiol. 2008. PMID: 18677297 No abstract available.

6

Management of antithrombotic therapy in patients undergoing invasive procedures.

Baron TH, Kamath PS, McBane RD. Baron TH, et al. N Engl J Med. 2013 May 30;368(22):2113-24. doi: 10.1056/NEJMra1206531. N Engl J Med. 2013. PMID: 23718166 Review. No abstract available.

7

Triple antithrombotic therapy for atrial fibrillation and coronary stents.

Shmyr D, Van der Merwe V, Yakiwchuk E, Barry A, Kosar L. Shmyr D, et al. Can Fam Physician. 2017 May;63(5):375-381. Can Fam Physician. 2017. PMID: 28500198 Free PMC article. Review. No abstract available.

8

[Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].

Själander A, Wallentin L, Rosenqvist M, Svensson P. Själander A, et al. Lakartidningen. 2008 Sep 10-16;105(37):2478-80. Lakartidningen. 2008. PMID: 19006862 Swedish. No abstract available.

9

Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI).

Lip GY, Huber K, Andreotti F, Arnesen H, Airaksinen JK, Cuisset T, Kirchhof P, Marín F; Consensus Document of European Society of Cardiology Working Group on Thrombosis. Lip GY, et al. Eur Heart J. 2010 Jun;31(11):1311-8. doi: 10.1093/eurheartj/ehq117. Epub 2010 May 6. Eur Heart J. 2010. PMID: 20447945

10

Antithrombotic management and type of stent in atrial fibrillation patients undergoing percutaneous coronary intervention.

Ruiz-Nodar JM, Marín F, Lip GY. Ruiz-Nodar JM, et al. Rev Esp Cardiol (Engl Ed). 2013 Jan;66(1):12-6. doi: 10.1016/j.recesp.2012.07.018. Epub 2012 Oct 23. Rev Esp Cardiol (Engl Ed). 2013. PMID: 23098580 English, Spanish. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

161 results

Results by year